Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

Panelists discuss how amyloid-targeting therapies for Alzheimer disease represent a breakthrough drug class that works by ...

W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the ...

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

According to the authors, the research opens up new possibilities for developing the next generation of ChE inhibitors that ...

Worley was part of a team that showed how the loss of one of the two proteins used in the test disrupts synapses and leads to ...

In this video Thomas Wisniewski, MD, director of NYU Langone’s Alzheimer’s Disease Research Center, discusses recent advancements in Alzheimer's disease care.

Researchers have developed a blood test based on a protein biomarker for tau tangles that can help diagnose Alzheimer’s ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced the launch of a new laboratory blood test designed to help ...

Roche Holdings AG (OTC:RHHBY) on Thursday presented new data at the AD/PD 2025 International Conference on Alzheimer’s and ...